BayBG has taken a 'stille Beteiligung' position in MLL Münchner Leukämielabor GmbH, Munich. The reason for the investment was the spinout of the laboratory realised by doctors and biologists working at the Munich university clinic. The volume of the transaction is EUR 300,000.
Deal is Sortera's 13th acquisition since it was established in 2006
Alpina began its ERP software buy-and-build platform with the acquisition of Oxaion in 2015
Noema plans to use the fresh capital to fund the development of its clinical-stage pipeline
Around £500,000 of the capital was raised from 866 new investors in Seedrs' network